Acg Wealth Biogen Inc. Transaction History

Acg Wealth

$437 Million
Q3 2022

A detailed history of Acg Wealth transactions in Biogen Inc. stock. As of the latest transaction made, Acg Wealth holds 11,213 shares of BIIB stock, worth $2.18 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

11,213

Previous 12,828 12.59%

Holding current value

$2.18 Million

Previous $2.62 Million 14.45%

% of portfolio

0.68%

Previous 0.53%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$194.69 - $268.46 $314,424 - $433,562	-1,615 Reduced 12.59%	11,213 $2.99 Million
Q2 2022 Jul 13, 2022	SELL	$187.54 - $223.02 $73,140 - $86,977	-390 Reduced 2.95%	12,828 $2.62 Million
Q1 2022 Apr 07, 2022	SELL	$193.77 - $244.14 $1.72 Million - $2.16 Million	-8,864 Reduced 40.14%	13,218 $2.78 Million
Q4 2021 Jan 18, 2022	SELL	$223.92 - $287.77 $1.32 Million - $1.7 Million	-5,891 Reduced 21.06%	22,082 $5.3 Million
Q3 2021 Nov 01, 2021	SELL	$282.99 - $369.05 $74,992 - $97,798	-265 Reduced 0.94%	27,973 $7.92 Million
Q2 2021 Aug 06, 2021	BUY	$259.0 - $414.71 $1.62 Million - $2.6 Million	6,269 Added 28.54%	28,238 $9.78 Million
Q1 2021 May 03, 2021	BUY	$242.95 - $284.63 $308,060 - $360,910	1,268 Added 6.13%	21,969 $6.15 Million
Q4 2020 Feb 02, 2021	SELL	$236.26 - $355.63 $47,960 - $72,192	-203 Reduced 0.97%	20,701 $5.07 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $275,890 - $318,549	1,042 Added 5.25%	20,904 $5.93 Million
Q2 2020 Oct 07, 2020	SELL	$258.66 - $342.55 $112,775 - $149,351	-436 Reduced 2.15%	19,862 $5.31 Million
Q1 2020 Oct 07, 2020	SELL	$268.85 - $341.04 $157,546 - $199,849	-586 Reduced 2.81%	20,298 $6.42 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $133,796 - $184,874	-608 Reduced 2.83%	20,884 $6.2 Million
Q3 2019 Oct 30, 2019	BUY	$217.44 - $243.88 $318,549 - $357,284	1,465 Added 7.32%	21,492 $5 Million
Q2 2019 Aug 06, 2019	BUY	$219.29 - $241.72 $1.58 Million - $1.74 Million	7,219 Added 56.36%	20,027 $4.68 Million
Q1 2019 Apr 25, 2019	BUY	$216.71 - $338.96 $384,226 - $600,976	1,773 Added 16.07%	12,808 $3.03 Million
Q4 2018 Jan 14, 2019	BUY	$278.5 - $352.75 $994,802 - $1.26 Million	3,572 Added 47.86%	11,035 $3.32 Million
Q3 2018 Oct 09, 2018	BUY	$293.51 - $383.83 $96,271 - $125,896	328 Added 4.6%	7,463 $2.64 Million
Q2 2018 Jul 26, 2018	SELL	$257.52 - $306.91 $138,030 - $164,503	-536 Reduced 6.99%	7,135 $2.07 Million
Q1 2018 Apr 10, 2018	BUY	$260.13 - $367.91 $72,056 - $101,911	277 Added 3.75%	7,671 $2.1 Million
Q4 2017 Feb 08, 2018	SELL	$307.64 - $344.58 $87,985 - $98,549	-286 Reduced 3.72%	7,394 $2.36 Million
Q3 2017 Nov 07, 2017	BUY	$281.15 - $329.69 $18,274 - $21,429	65 Added 0.85%	7,680 $2.41 Million
Q2 2017 Aug 14, 2017	BUY	N/A	7,615	7,615 $2.07 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acg Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Acg Wealth with notifications on news.

Account